ライフサイエンスコーパス: preterm delivery

1 ith the recognition of brain injuries due to preterm delivery.

2 The associations are similar for the risk of preterm delivery.

3 the expression of inflammatory mediators and preterm delivery.

4 l secretions has been used as a predictor of preterm delivery.

5 ity-related risks were highest for extremely preterm delivery.

6 ks of preterm delivery, especially extremely preterm delivery.

7 age was associated with an increased risk of preterm delivery.

8 whether AS intake is indeed associated with preterm delivery.

9 ages is associated with an increased risk of preterm delivery.

10 complicated pregnancies requiring emergency preterm delivery.

11 n on perinatal mortality is mediated through preterm delivery.

12 sma parvum serovar 3 either 7 or 70 d before preterm delivery.

13 , this was not significantly associated with preterm delivery.

14 placental insufficiency against the risks of preterm delivery.

15 therapy for women presenting with threatened preterm delivery.

16 ty, as measured by apparent temperature, and preterm delivery.

17 ons responsible for impaired development and preterm delivery.

18 n pregnancy are at high risk for spontaneous preterm delivery.

19 sions in medically indicated and spontaneous preterm delivery.

20 e presence of the organism may contribute to preterm delivery.

21 the maternal-placental interface in cases of preterm delivery.

22 contributes to increased risk of spontaneous preterm delivery.

23 ed small-for-gestational age (SGA) birth and preterm delivery.

24 vaginosis in pregnant women at high risk for preterm delivery.

25 in a mouse model of inflammation-associated preterm delivery.

26 how to classify disorders that lead to such preterm delivery.

27 vaginosis in pregnant women at low risk for preterm delivery.

28 l pessary can reduce the risk of spontaneous preterm delivery.

29 echanism of pregnancy complications, such as preterm delivery.

30 cy are associated with an increased risk for preterm delivery.

31 ere used to test for effects of treatment on preterm delivery.

32 nd biochemical abnormalities associated with preterm delivery.

33 ncy was associated with an increased risk of preterm delivery.

34 es (both maternal and fetal) associated with preterm delivery.

35 uggested to play a role in infection-induced preterm delivery.

36 PI was associated with an increased risk of preterm delivery.

37 n then faces increased risks associated with preterm delivery.

38 rved between caffeine or any metabolites and preterm delivery.

39 weight or preterm low birth weight, but not preterm delivery.

40 evels in early pregnancy are associated with preterm delivery.

41 aternal infections have been associated with preterm delivery.

42 ation was found between quartiles of CRP and preterm delivery.

43 ated with a > 2-fold increase in the risk of preterm delivery.

44 air deletion allele may be a risk factor for preterm delivery.

45 rotein (CRP), a marker of inflammation, with preterm delivery.

46 ecisions with families at risk for extremely preterm delivery.

47 s not substantially reduce the risk of early preterm delivery.

48 nsertion of a Shirodkar suture reduces early preterm delivery.

49 nancy complications such as miscarriages and preterm delivery.

50 is a major factor that predisposes women to preterm delivery.

51 ; its failure is associated with abortion or preterm delivery.

52 s) used during pregnancy on fetal growth and preterm delivery.

53 cted pregnant women and were associated with preterm delivery.

54 nancy and to evaluate their association with preterm delivery.

55 on during pregnancy may be a risk factor for preterm delivery.

56 of these babies dying as a direct result of preterm delivery.

57 ly associated with fetal mortality and early preterm delivery.

58 m in the index pregnancy or had a history of preterm delivery.

59 activity was increased in human amnion from preterm deliveries.

60 o assess coverage for these interventions in preterm deliveries.

61 effects were recorded for laser conisation (preterm delivery 1.71, 0.93-3.14).

62 LETZ) was also significantly associated with preterm delivery (1.70, 1.24-2.35, 156/1402 [11%] vs 120

63 2%, 95% CI -8.28, -0.60, p = 0.024), overall preterm delivery (-11.72%, 95% CI -15.87, -7.35, p<0.001

64 n pregnancy (n = 669) had increased risks of preterm delivery (164/664; 25% versus 144/2200; 6.5%; ad

65 60), any major birth defect (1233 vs. 4932), preterm delivery (1792 vs. 7168), and birth of infants a

66 in 27.8% of ongoing pregnancies and included preterm delivery (20.8%), small for gestational age (8.3

67 elivery (360 [35.4%]), preterm labor without preterm delivery (269 [26.4%]), and miscarriage (262 [25

68 The 3 most frequent adverse events were preterm delivery (360 [35.4%]), preterm labor without pr

69 Forty women had preterm delivery, 39 women delivered a low-birth-weight

70 nd 120% increased odds), and reduced odds of preterm delivery (50% and 60% decreased odds).

71 (hazard ratio, 1.64; 95% CI, 1.42 to 1.88); preterm delivery, 53.3% vs. 17.8% (hazard ratio, 4.68; 9

72 nce odds ratio, 1.12; 95% CI, 0.69 to 1.82), preterm delivery (6.2% and 5.2%; prevalence odds ratio,

73 ata show a 3.8-fold reduction in the rate of preterm delivery, a decrease in periodontal pathogen loa

74 idemiologists can use recurrence patterns of preterm delivery across generations to assess the relati

75 le (adjusted HR = 1.29, 95% CI: 1.01, 1.65), preterm delivery (adjusted HR = 1.91, 95% CI: 1.35, 2.70

76 as also associated with an increased risk of preterm delivery (adjusted OR: 1.25; 95% CI: 1.08, 1.45)

77 n allele had a significantly greater risk of preterm delivery [adjusted odds ratio (AOR): 3.0; 95% CI

78 xtent that unmeasured pathologies triggering preterm delivery also directly harm the fetus, they will

79 There were 19 (7%) preterm deliveries among the 268 subjects.

80 ved between first trimester sCD14 levels and preterm delivery among HIV-infected women.

81 The increased risk of preterm delivery among mothers born preterm is consisten

82 ociated with the risk of low birth weight or preterm delivery among mothers who have had at least 2 l

83 been born preterm and calculated the risk of preterm delivery among their firstborn.

84 Improved management of preterm deliveries and improved collection, processing,

85 Treatment with (+)-naloxone prevented preterm delivery and alleviated fetal demise in utero el

86 We compared preterm delivery and birth weight (BW) outcomes (low BW

87 een smoking and preeclampsia with respect to preterm delivery and birth weight; smokers who developed

88 nal abnormalities, structural abnormalities, preterm delivery and death.

89 ts during pregnancy protect newborns against preterm delivery and early neonatal death, but the impac

90 Severity was associated with preterm delivery and fetal loss.

91 acts via TLR2 to suppress TLR ligand-induced preterm delivery and inflammatory responses.

92 as a modifiable independent risk factor for preterm delivery and low birth weight.

93 Reductions were observed in the risk of preterm delivery and small for gestational age 3 mo prio

94 determine the impact of this legislation on preterm delivery and small for gestational age.

95 iated with adverse birth outcomes, including preterm delivery and small-for-gestational-age (SGA) bir

96 Severe disease is complicated by spontaneous preterm delivery and stillbirth.

97 The prevalence of preterm delivery and the correlation between gestational

98 ery was associated with an increased risk of preterm delivery and uterine dehiscence at delivery.

99 eous abortion, intrauterine-fetal-death, and preterm delivery) and neonatal sequelae [small for gesta

100 orn saliva, intrauterine growth restriction, preterm deliveries, and controls.

101 GH vs no HDP, 1.62 (95% CI, 1.46-1.79) after preterm delivery, and 1.86 (95% CI, 1.15-3.02) after sti

102 14) for Q3, and 8.86 (5.66-13.86) for Q4 for preterm delivery, and 2.29 (95% CI 1.08-4.84) for Q2, 3.

103 o developed preeclampsia had a lower risk of preterm delivery, and a lower adjusted mean difference i

104 ing median regression; and low birth weight, preterm delivery, and being small for gestational age us

105 spontaneous abortions, perinatal mortality, preterm delivery, and birth weight.

106 30 kg/m(2) or higher, obstetric hemorrhage, preterm delivery, and caesarean section (ARs, >/=637/100

107 eriod, no maternal smoking during pregnancy, preterm delivery, and congenital malformations.

108 ing outcomes were studied: cesarean section, preterm delivery, and early preterm delivery; small for

109 e birth outcomes (small for gestational age, preterm delivery, and low birth weight) were evaluated.

110 Cox regression was used for preterm delivery, and Poisson regression for other outco

111 increased risk of fetal growth restriction, preterm delivery, and preeclampsia.

112 llitus, hypertensive disorders of pregnancy, preterm delivery, and size for gestational age with calc

113 r hemorrhagic stroke, and oophorectomy, HDP, preterm delivery, and stillbirth for any stroke.

114 , including intrauterine growth restriction, preterm delivery, and stillbirth.

115 In pregnancy it may cause fetal loss or a preterm delivery, and the neonate is prone to neonatal s

116 lements) had a significantly greater risk of preterm delivery (AOR: 5.5; 95% CI: 1.5, 20.4; P = 0.01)

117 oaches for the treatment of labor leading to preterm delivery are inadequate and our understanding of

118 Current therapeutic approaches to preterm delivery are ineffective and present serious ris

119 tween overweight and obesity and subtypes of preterm delivery are not clear.

120 more large-scale studies of temperature and preterm delivery are warranted.

121 e found significant elevated risks of having preterm delivery as RR = 3.08, 95% confidence interval (

122 esity are associated with increased risks of preterm delivery, asphyxia-related neonatal complication

123 iteria, and race/ethnicity influence the HCA-preterm delivery association and that HCA contributes to

124 rticosteroids, in spontaneous, uncomplicated preterm deliveries at 26-34 weeks' gestation.

125 Spontaneous preterm delivery at <35 weeks was significantly associat

126 istic regression models, medically indicated preterm delivery at <35 weeks was significantly associat

127 actors varied between incident and recurrent preterm delivery at <37 weeks.

128 s C.albicans or saline at 3 or 5 days before preterm delivery at 122 days of gestation.

129 7 days (2- and 7-day repeat exposure) before preterm delivery at 124 days gestation (term=150 days).

130 tween June 25, 1991, and June 30, 1997, with preterm delivery at 35 weeks or earlier associated with

131 er associated with subclinical IAI (n = 11), preterm delivery at 35 weeks or earlier without IAI (n =

132 Spontaneous preterm delivery at 35-36 weeks was significantly associ

133 Among preterm deliveries before 35 weeks excluding those medic

134 The proportion of preterm delivery before 33 weeks was similar in both gro

135 gher rates than zidovudine-based ART of very preterm delivery before 34 weeks (6.0% vs. 2.6%, P=0.04)

136 n African Americans, HCA was associated with preterm delivery before 35 weeks.

137 zidovudine alone (16.9% vs. 8.9%, P=0.004); preterm delivery before 37 weeks was more frequent with

138 grouped the multiple disorders that lead to preterm delivery before the 28th week of gestation in a

139 n models to identify factors associated with preterm delivery (before 37 weeks' gestation) and small

140 ssessed 112 women with at least one previous preterm delivery between 16 and 34 weeks' gestation.

141 ts indicate that fFN is not only a marker of preterm delivery but also plays a significant role in th

142 PI-based HAART was associated with increased preterm delivery but not increased infant hospitalizatio

143 ratures with adverse birth outcomes, such as preterm delivery, but other birth outcomes have not been

144 Obesity increases the risk of preterm delivery, but the associations between overweigh

145 GSI treatment prevents PGN+poly(I:C)-induced preterm delivery by 55.5% and increased the number of li

146 timated SGA birth by 12.9% and overestimated preterm delivery by 8.7%.

147 While preterm delivery causes both small babies and high morta

148 upture of membranes) and medically indicated preterm delivery (cesarean delivery before onset of labo

149 tes of antenatal corticosteroid use, induced preterm deliveries, cesarean deliveries, and surfactant

150 PI was associated with an increased risk of preterm delivery, compared with any other combination (o

151 asone administered to women at risk for late preterm delivery decreases the risks of neonatal morbidi

152 o magnesium sulfate before anticipated early preterm delivery did not reduce the combined risk of mod

153 Preterm delivery, early maternal age, and ethnic group w

154 h the lowest quartile set as reference) with preterm delivery, early-term delivery, low birthweight,

155 ancy were associated with increased risks of preterm delivery, especially extremely preterm delivery.

156 y 31 operations associated with 1 additional preterm delivery, every 39 operations associated with 1

157 Risks of preterm deliveries (extremely, 22-27 weeks; very, 28-31

158 otency with mode of delivery, birth defects, preterm delivery, fetal death, and low Apgar score.

159 Orofacial cleft, low birth weight, preterm delivery, fetal death, low Apgar score, and mode

160 sure with orofacial cleft, low birth weight, preterm delivery, fetal death, low Apgar score, and mode

161 orticosteroid exposure with orofacial cleft, preterm delivery, fetal death, low Apgar score, and mode

162 The difference concerned mainly induced preterm delivery for maternal or fetal indications (5.6%

163 nt associations for apparent temperature and preterm delivery found in this study, more large-scale s

164 Using a mouse model of infection-induced preterm delivery, gestational tissues were collected 8 h

165 Preterm delivery has been shown to be associated with in

166 feine intake during pregnancy on the risk of preterm delivery has been studied for the past 3 decades

167 Risk factors for preterm delivery have been described, but whether risk f

168 Associations between stress hormones and preterm delivery have not been fully explored.

169 Prior preterm delivery history is important when assessing sub

170 risk factors differ in the context of prior preterm delivery history is less understood.

171 are used to treat pregnant women at risk for preterm delivery; however, prenatal exposure to GCs may

172 (May 2002-June 2005) of Iowa SGA births and preterm deliveries identified from birth records (n = 2,

173 T) use in pregnancy has been associated with preterm deliveries in some observational studies.

174 ions between placental vascular findings and preterm delivery in 1,053 subcohort women (239 preterm,

175 cient (ADC) of the cervix is associated with preterm delivery in asymptomatic patients with a sonogra

176 2 was positively associated with spontaneous preterm delivery in NYC.

177 nsive ablation does not decrease any risk of preterm delivery in subsequent pregnancies.

178 prepregnancy lifestyle and CVD risk factors, preterm delivery in the first pregnancy was associated w

179 nancy factors were associated with recurrent preterm delivery, including alcohol, thyroid disease, an

180 Risks of medically indicated preterm deliveries increased with BMI among overweight a

181 Risks of extremely, very, and moderately preterm deliveries increased with BMI and the overweight

182 Risk of spontaneous extremely preterm delivery increased with BMI among obese women (B

183 bsequently may lead to complications such as preterm delivery, intrauterine growth retardation, and p

184 Although preterm delivery is a major global health issue, its cau

185 Preterm delivery is a powerful predictor of newborn morb

186 positive pregnant women an increased rate of preterm delivery is associated with highly active antire

187 Concordance for preterm delivery is elevated in monozygotic compared wit

188 Preterm delivery is independently predictive of CVD and

189 The chorioamnionitis associated with preterm delivery is often polymicrobial with ureaplasma

190 differences in maternal anemia, stillbirths, preterm delivery, LBW, or all-cause mortality of infants

191 regnancy is associated with a higher risk of preterm delivery, low birth weight, and complications su

192 ternal DNA in cord blood was associated with preterm delivery, low birth weight, and maternal immunos

193 Rates of preterm delivery, low birth weight, and neonatal mortali

194 The outcome measures were preterm delivery, low birth weight, and stillbirth.

195 immunodeficiency virus type 1 transmission, preterm delivery, low birth weight, cervical cancer, and

196 atory nicotine inhalation is associated with preterm delivery, low birth weight, fetal growth retarda

197 e, race or ethnic origin, pre-pregnancy BMI, preterm delivery, low birthweight, maternal antibiotic u

198 percentile, preterm delivery <37 weeks, and preterm delivery <34 weeks with minimal heterogeneity.

199 sits to determine the relationship to cases (preterm delivery <37 weeks' gestation) and controls (ter

200 , SGA <10th percentile, SGA <5th percentile, preterm delivery <37 weeks, and preterm delivery <34 wee

201 the use of a sonic toothbrush on the rate of preterm delivery (<37 weeks gestation).

202 he risk of having adverse neonatal outcomes: preterm delivery (<37 weeks of gestation), low birth wei

203 the focus of epidemiologic investigation in preterm delivery (<37 weeks' gestation), which is a lead

204 Risk factors for preterm delivery (<37 weeks) and differences by randomiz

205 ight (in grams), low birth weight (<2500 g), preterm delivery (<37 weeks), small for gestational age

206 o estimate the pooled effect of treatment on preterm delivery (<37 weeks, <34 weeks, or <32 weeks) an

207 conisation was significantly associated with preterm delivery (<37 weeks; relative risk 2.59, 95% CI

208 o estimate the pooled effect of treatment on preterm delivery (<37, <34, and <32 weeks); low birthwei

209 In the setting of a prior preterm delivery, many risk factors did not persist.

210 Disorders leading to preterm delivery may be separated into two groups: those

211 nfants of pregnant women at risk of imminent preterm delivery may benefit from its use.

212 cental histologic chorioamnionitis (HCA) and preterm delivery may result from variations in HCA defin

213 Risks of preterm delivery, meconium-stained amniotic fluid, and s

214 k ratios of the natural direct and indirect (preterm delivery-mediated) effects of abruption on morta

215 of identifying the high-risk group for early preterm delivery might be by transvaginal sonographic me

216 In a mouse inflammation-induced preterm delivery model, intrauterine administration of S

217 , SGA); and "severe" combined outcome (early preterm delivery, NICU, SGA).

218 CKD stage shift; "general" combined outcome (preterm delivery, NICU, SGA); and "severe" combined outc

219 type of antiretroviral therapy were sought: preterm delivery occurred in 14.2% of the 211 deliveries

220 curred in 4%, neonatal death occurred in 1%, preterm delivery occurred in 9%, and SGA neonate occurre

221 ature were associated with increased risk of preterm delivery (odds ratio = 2.55, 95% confidence inte

222 ART was the most significant risk factor for preterm delivery [odds ratio = 2.03, 95% confidence inte

223 Mothers born preterm had a relative risk for preterm delivery of 1.54 (95% confidence interval (CI):

224 e of increasing indicated preterm births and preterm delivery of artificially conceived multiple preg

225 sting a mechanism for the adverse effects of preterm delivery on cognitive function.

226 ated hypertension and diabetes, as well as a preterm delivery or a low birth weight delivery, to exce

227 association between maternal PHIV status and preterm delivery or infant BW outcomes is reassuring.

228 rphism in the DHFR gene is a risk factor for preterm delivery or low birth weight.

229 ngthened after excluding medically indicated preterm deliveries (OR = 4.9, 95% CI: 2.0, 11.8); and st

230 ntly decreased incidence odds ratio (OR) for preterm delivery (OR = 0.26; 95% confidence interval = 0

231 the lowest quartile had an increased risk of preterm delivery (OR: 1.72; 95% CI: 1.14, 2.60) and chil

232 te birth outcome (small for gestational age, preterm delivery, or low birth weight).

233 , it did not significantly alter the risk of preterm delivery (P=0.70; hazard ratio for treatment gro

234 identified as an independent risk factor for preterm delivery, perinatal mortality, and other complic

235 The remainder were complicated by preterm delivery, preeclampsia, and/or small-for-gestati

236 Outcomes included stillbirths (SBs), preterm delivery (PTD), small for gestational age (SGA),

237 sidential environment may be associated with preterm delivery (PTD), though few studies exist.

238 plants and adverse birth outcomes including preterm delivery (PTD), very preterm delivery (VPTD), an

239 es treatment during pregnancy in relation to preterm delivery (PTD), we conducted a multicenter, memb

240 nsistently associated with increased risk of preterm delivery (PTD).

241 tis (HCA), a condition linked to spontaneous preterm delivery (PTD).

242 uption and excess thrombin generation elicit preterm delivery (PTD).

243 Inflammation is frequently linked to preterm delivery (PTD).

244 rupture of the membranes (PPROM) as well as preterm delivery (PTD).

245 ng malaria are related to pregnancy loss and preterm delivery (PTD).

246 small studies have demonstrated an increased preterm delivery rate, but a recent retrospective United

247 ies which factors explain the differences in preterm delivery rates and potentially the association o

248 Cesarean delivery and preterm delivery rates did not differ.

249 Preterm delivery rates were higher among 267 women in th

250 n to pregnant women at imminent risk of very preterm delivery reduces the risk of cerebral palsy in e

251 very association and that HCA contributes to preterm delivery-related ethnic disparity.

252 of BV and to reduce serious sequelae such as preterm delivery, remains an acknowledged but unresolved

253 : 0.67, 1.43; Pinteraction = 0.02 and <0.01) preterm delivery, respectively.

254 story is important when assessing subsequent preterm delivery risk factors.

255 onfer protection from known second pregnancy preterm delivery risk factors.

256 aternal genes have little, if any, effect on preterm delivery risk.

257 ), stillbirth (RR, 3.94; 95% CI, 2.60-5.96), preterm delivery (RR, 2.21; 95% CI, 1.47-3.31), and smal

258 ear dose-response relationships with risk of preterm delivery (S-shaped, p<0.0001) and low birthweigh

259 ssociations between maternal PHIV status and preterm delivery, SGA, or LBW were observed.

260 Assessment of any effect on preterm delivery should be included in future maternal G

261 fetal growth and cautious decision making on preterm delivery should therefore be reinforced.

262 n of betamethasone to women at risk for late preterm delivery significantly reduced the rate of neona

263 rst born, maternal smoking during pregnancy, preterm delivery, small weight for gestational age, cesa

264 ed: maternal and fetal death; malformations; preterm delivery; small for gestational age (SGA) baby;

265 esarean section, preterm delivery, and early preterm delivery; small for gestational age (SGA); need

266 s between each preterm risk factor and prior preterm delivery status to explore whether risk factors

267 The main outcome measures investigated were preterm delivery, stillbirth, and neonatal unit admissio

268 utcome variable (i.e., term (referent) and 3 preterm delivery subtypes: spontaneous; premature ruptur

269 e sensitivity of this algorithm is lower for preterm deliveries, suggesting limited validity to asses

270 ministration of SP-A significantly inhibited preterm delivery, suppressed the expression of proinflam

271 result in a lower rate of spontaneous early preterm delivery than the rate with expectant management

272 infection is considered as a risk factor for preterm delivery, the localization of oral bacteria or t

273 h intake of AS beverages was associated with preterm delivery; the adjusted OR for those drinking >1

274 different in women with versus without prior preterm delivery using medical records of the first and

275 comes including preterm delivery (PTD), very preterm delivery (VPTD), and term low birth weight (LBW)

276 In the LTx and RTx groups, the percentage of preterm deliveries was 48.8% (68.8% in the RTx and 43.2%

277 The rate of preterm deliveries was higher in the lithium group compa

278 women (BMI 18.5-<25), the rate of extremely preterm delivery was 0.17%.

279 of increased mortality risk mediated through preterm delivery was 28.1%, with even higher proportions

280 e was 6%, large for gestational age was 14%, preterm delivery was 7%, substantial postpartum weight r

281 ease (95% confidence interval: 6.0, 11.3) in preterm delivery was associated with a 10 degrees F (5.6

282 In women with stage 1 CKD, preterm delivery was associated with baseline hypertensi

283 Preterm delivery was associated with maternal asthma for

284 Preterm delivery was associated with maternal drug-treat

285 sm on parasite density, low birth weight, or preterm delivery was discernible.

286 The risk of spontaneous preterm delivery was increased in the highest versus low

287 variate analysis, risk for preterm and early-preterm delivery was linked to CKD stage (2-5 vs 1: rela

288 Preterm delivery was seen in 780 (9%, 95% CI 8-9) of 886

289 When preterm delivery was split into moderate preterm (>/=32

290 Preterm delivery was the primary outcome, and data were

291 adverse birth outcomes: crude estimates for preterm delivery were 6.3% of vaccinated and 7.8% of unv

292 ted odds ratios (ORs [95% CIs]) of extremely preterm delivery were as follows: BMI 25 to less than 30

293 tions, whereas small for gestational age and preterm delivery were associated with higher blood press

294 sociations between each cytokine and SGA and preterm delivery were evaluated using log binomial regre

295 Factors associated with preterm delivery were history of injecting drug use (adj

296 Gestational age and preterm delivery were statistically significantly associ

297 ypothesis that a woman is at greater risk of preterm delivery when she has had elevated exposure to a

298 ot recurrent (RR = 1.09, 95% CI: 0.71, 1.19) preterm delivery, whereas alcohol was associated with an

299 57BL/6J mice on embryonic day 14.5 triggered preterm delivery within 24 h.

300 tients with subclinical IAI, in 2 of 11 with preterm delivery without IAI, and in 0 of 11 with preter